Literature DB >> 3380331

Arginine vasopressin receptors in pig cerebral microvessels, cerebral cortex and hippocampus.

A F Pearlmutter1, M Szkrybalo, Y Kim, S I Harik.   

Abstract

We tested for the presence of arginine vasopressin (AVP) receptors in pig cerebral microvessels, cerebral cortex and hippocampus by specific binding methods with [3H]AVP as the ligand. The specific binding of [3H]AVP to all preparations was saturable and Scatchard analysis indicated a single class of high affinity binding sites (dissociation constant of 1-2 nM). Maximal binding capacity in cerebral microvessels was about 60% that of the cerebral cortex; and there were no apparent differences in the maximal binding capacity between cerebral cortex and hippocampus. These findings suggest the existence of AVP receptor sites in cerebral microvessels and support the hypothesis that AVP has a role in the control of the brain microcirculation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380331     DOI: 10.1016/0304-3940(88)90156-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin.

Authors:  Tina I Lam; Phyllis M Wise; Martha E O'Donnell
Journal:  Am J Physiol Cell Physiol       Date:  2009-05-20       Impact factor: 4.249

2.  Evaluating the involvement of cerebral microvascular endothelial Na+/K+-ATPase and Na+-K+-2Cl- co-transporter in electrolyte fluxes in an in vitro blood-brain barrier model of dehydration.

Authors:  Kasper Lykke; Mette Assentoft; Sofie Hørlyck; Hans Cc Helms; Anca Stoica; Trine L Toft-Bertelsen; Katerina Tritsaris; Frederik Vilhardt; Birger Brodin; Nanna MacAulay
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-10       Impact factor: 6.200

Review 3.  Arginine Vasopressin and Copeptin in Perinatology.

Authors:  Katrina Suzanne Evers; Sven Wellmann
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.